These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15080308)

  • 1. Expression of beta-catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas.
    Bismar TA; Humphrey PA; Grignon DJ; Wang HL
    Am J Clin Pathol; 2004 Apr; 121(4):557-63. PubMed ID: 15080308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S; Fujimori M; Shibata S; Okajima M; Ishizaki Y; Kurihara T; Miyata Y; Iseki M; Shimizu Y; Tokumoto N; Ozaki S; Asahara T
    BMC Cancer; 2006 Feb; 6():31. PubMed ID: 16451736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear beta-catenin accumulation as a prognostic factor in Dukes' D human colorectal cancers.
    Miyamoto S; Endoh Y; Hasebe T; Ishii G; Kodama K; Goya M; Ono M; Saitoh N; Chiba T; Ochiai A
    Oncol Rep; 2004 Aug; 12(2):245-51. PubMed ID: 15254684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma.
    Zhang W; Tang W; Inagaki Y; Qiu M; Xu HL; Li X; Sugawara Y; Nagawa H; Nakata M; Kokudo N
    Oncol Rep; 2008 Nov; 20(5):1013-9. PubMed ID: 18949395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human scribble accumulates in colorectal neoplasia in association with an altered distribution of beta-catenin.
    Kamei Y; Kito K; Takeuchi T; Imai Y; Murase R; Ueda N; Kobayashi N; Abe Y
    Hum Pathol; 2007 Aug; 38(8):1273-81. PubMed ID: 17509663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
    Wu W; Zhang X; Yan X; Wang J; Zhang J; Li Y
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):264-7. PubMed ID: 12515622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal adenocarcinoma involving the prostate: report of 9 cases.
    Osunkoya AO; Netto GJ; Epstein JI
    Hum Pathol; 2007 Dec; 38(12):1836-41. PubMed ID: 17868775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
    Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T
    Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin expression as a prognostic indicator in cervical adenocarcinoma.
    Imura J; Ichikawa K; Takeda J; Fujimori T
    Int J Mol Med; 2001 Oct; 8(4):353-8. PubMed ID: 11562771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Awaya H; Takeshima Y; Amatya VJ; Ishida H; Yamasaki M; Kohno N; Inai K
    Pathol Int; 2005 Jan; 55(1):14-8. PubMed ID: 15660698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
    Hornick JL; Farraye FA; Odze RD
    Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
    Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
    Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
    Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
    Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.